£1.1M
The pre-seed round was led by QUBIS Innovation Fund and will support clinical trial preparations and engineering hires.
TD
Transdermal Diagnostics
Transdermal Diagnostics develops a needle-free platform for continuous blood sugar monitoring.
Bristol, UK—Founded 2021
£1.1MTotal raised
Transdermal Diagnostics is a Bristol-based medical technology spin-out developing a needle-free platform for continuous blood sugar monitoring. The firm uses miniaturised biosensors on wearable patches to track health biomarkers without puncturing the skin.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Transdermal Diagnostics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Adelina Ilie
Chief Scientific Officer
Adelina is a co-founder and chief scientific officer at Transdermal Diagnostics. She also serves as a reader in nanoscience at the University of Bath.
LinkedIn
Richard Guy
Company director
Richard brings academic and founding experience in pharmaceutical sciences, holding professorships at the University of Bath, the University of Geneva, and UCSF. He serves as director and co-founder of Transdermal Diagnostics.
LinkedIn